MEDIPART ApS: Financial statements 2022
CVR: 28895399
Source: annual report 2022, Danish Business Authority
01/08/2021 – 31/07/2022
MEDIPART ApS (CVR 28895399) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -154,543 and a net result of DKK 861,558 compared with DKK 5,643,269 the year before. Equity in the 2022 report amounted to DKK 13,032,924. The solvency ratio was 92.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -154,543
- Profit/Loss
- DKK 861,558
- Equity
- DKK 13,032,924
- Total Assets
- DKK 14,122,077
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -155 t. | 862 t. | 13 mio. | 1 |
| 2021 | - | 7.6 mio. | 5.6 mio. | 12.2 mio. | 1 |
| 2020 | - | 8 t. | -373 t. | 6.5 mio. | 1 |
| 2019 | - | 1.3 mio. | 852 t. | 6.9 mio. | 1 |
| 2018 | - | 1.1 mio. | 389 t. | 6 mio. | - |
Official annual report
Keep an eye on MEDIPART ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MEDIPART ApS has published its annual report for 2021. Gross profit came to DKK 7,591,755, and the net result was DKK 5,643,269.
About MEDIPART ApS
MEDIPART ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Rikke Nygaard. The company is owned by Erik Nygaard. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -64,509 and a net result of DKK 138,106 compared with DKK 4,660 the year before. Equity in the 2025 report amounted to DKK 11,652,834.